162 related articles for article (PubMed ID: 34006700)
1. [Recommendations Guidance of Oncology Pharmaceuticals for Reproductive Toxicity in the USA and Europe].
Suzuki N
Gan To Kagaku Ryoho; 2021 May; 48(5):627-630. PubMed ID: 34006700
[TBL] [Abstract][Full Text] [Related]
2. Guidance on the need for contraception related to use of pharmaceuticals: the Japan Agency for Medical Research and Development Study Group for providing information on the proper use of pharmaceuticals in patients with reproductive potential.
Suzuki N; Takai Y; Yonemura M; Negoro H; Motonaga S; Fujishiro N; Nakamura E; Takae S; Yoshida S; Uesugi K; Ohira T; Katsura A; Fujiwara M; Horiguchi I; Kosaki K; Onodera H; Nishiyama H
Int J Clin Oncol; 2022 May; 27(5):829-839. PubMed ID: 35347493
[TBL] [Abstract][Full Text] [Related]
3. Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1.
Harada M; Kimura F; Takai Y; Nakajima T; Ushijima K; Kobayashi H; Satoh T; Tozawa A; Sugimoto K; Saji S; Shimizu C; Akiyama K; Bando H; Kuwahara A; Furui T; Okada H; Kawai K; Shinohara N; Nagao K; Kitajima M; Suenobu S; Soejima T; Miyachi M; Miyoshi Y; Yoneda A; Horie A; Ishida Y; Usui N; Kanda Y; Fujii N; Endo M; Nakayama R; Hoshi M; Yonemoto T; Kiyotani C; Okita N; Baba E; Muto M; Kikuchi I; Morishige KI; Tsugawa K; Nishiyama H; Hosoi H; Tanimoto M; Kawai A; Sugiyama K; Boku N; Yonemura M; Hayashi N; Aoki D; Osuga Y; Suzuki N
Int J Clin Oncol; 2022 Feb; 27(2):265-280. PubMed ID: 34973107
[TBL] [Abstract][Full Text] [Related]
4. Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2.
Tozawa A; Kimura F; Takai Y; Nakajima T; Ushijima K; Kobayashi H; Satoh T; Harada M; Sugimoto K; Saji S; Shimizu C; Akiyama K; Bando H; Kuwahara A; Furui T; Okada H; Kawai K; Shinohara N; Nagao K; Kitajima M; Suenobu S; Soejima T; Miyachi M; Miyoshi Y; Yoneda A; Horie A; Ishida Y; Usui N; Kanda Y; Fujii N; Endo M; Nakayama R; Hoshi M; Yonemoto T; Kiyotani C; Okita N; Baba E; Muto M; Kikuchi I; Morishige KI; Tsugawa K; Nishiyama H; Hosoi H; Tanimoto M; Kawai A; Sugiyama K; Boku N; Yonemura M; Hayashi N; Aoki D; Suzuki N; Osuga Y
Int J Clin Oncol; 2022 Feb; 27(2):281-300. PubMed ID: 35022887
[TBL] [Abstract][Full Text] [Related]
5. [Current Status and Issues in Providing Information about Contraception and Fertility Preservation in the Pharmaceutical Treatments for Female Cancer Patients].
Takai Y; Nakamura E
Gan To Kagaku Ryoho; 2021 May; 48(5):639-643. PubMed ID: 34006703
[TBL] [Abstract][Full Text] [Related]
6. Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.
Bennett CL; Schoen MW; Hoque S; Witherspoon BJ; Aboulafia DM; Hwang CS; Ray P; Yarnold PR; Chen BK; Schooley B; Taylor MA; Wyatt MD; Hrushesky WJ; Yang YT
Lancet Oncol; 2020 Dec; 21(12):e575-e588. PubMed ID: 33271114
[TBL] [Abstract][Full Text] [Related]
7. Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases.
Ono M; Matsumoto K; Boku N; Fujii N; Tsuchida Y; Furui T; Harada M; Kanda Y; Kawai A; Miyachi M; Murashima A; Nakayama R; Nishiyama H; Shimizu C; Sugiyama K; Takai Y; Fujio K; Morishige KI; Osuga Y; Suzuki N
Int J Clin Oncol; 2022 Feb; 27(2):301-309. PubMed ID: 34791542
[TBL] [Abstract][Full Text] [Related]
8. Rationales of delay and difference in regulatory review by Japan, the USA and Europe among new drugs first approved in Japan.
Tanaka M; Idei M; Sakaguchi H; Kato R; Sato D; Sawanobori K; Kawarasaki S; Hata T; Yoshizaki A; Nakamura M; Ikuma M
Br J Clin Pharmacol; 2021 Aug; 87(8):3279-3291. PubMed ID: 33511674
[TBL] [Abstract][Full Text] [Related]
9. Clinical Practice Guidelines for Fertility Preservation in Pediatric, Adolescent, and Young Adults with Cancer.
Suzuki N
Int J Clin Oncol; 2019 Jan; 24(1):20-27. PubMed ID: 29582194
[TBL] [Abstract][Full Text] [Related]
10. [Promotion of Equal Access to Medical Services for Children, Adolescent and Young Adult(CAYA)Cancer Patients with Reproductive Problems-A Nationwide Expansion of the Regional Oncofertility Network in Japan].
Takenaka M; Furui T; Takae S; Sugishita Y; Kawahara T; Shigematsu K; Kimura F; Horie A; Hara T; Kato M; Nishiyama H; Suzuki T; Miyachi M; Kanenishi K; Kubo K; Nakayama S; Kajiyama H; Takai Y; Suzuki N
Gan To Kagaku Ryoho; 2020 Dec; 47(12):1691-1696. PubMed ID: 33342985
[TBL] [Abstract][Full Text] [Related]
11. Alternatives to Monkey Reproductive Toxicology Testing for Biotherapeutics.
Hoberman AM; Maki K; Mikashima F; Naota M; Wange RL; Lansita JA; Weis SL
Int J Toxicol; 2023 Dec; 42(6):467-479. PubMed ID: 37714565
[TBL] [Abstract][Full Text] [Related]
12. [Current Status of Oncofertility in Adolescent and Young Adult (AYA) Generation Cancer Patients in Japan - National Survey of Oncologists].
Furui T; Takai Y; Kimura F; Kitajima M; Nakatsuka M; Morishige K; Yamamoto K; Hashimoto H; Matsumoto K; Ozono S; Horibe K; Suzuki N
Gan To Kagaku Ryoho; 2018 May; 45(5):841-846. PubMed ID: 30026448
[TBL] [Abstract][Full Text] [Related]
13. Conflicting meal recommendations for oral oncology drugs: pose risks to patient care?
Yu G; Wu DN; Gong Y; Li GF; Zhou HH
Eur J Clin Pharmacol; 2018 Jun; 74(6):833-842. PubMed ID: 29536134
[TBL] [Abstract][Full Text] [Related]
14. EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists.
Dolmans MM; Lambertini M; Macklon KT; Almeida Santos T; Ruiz-Casado A; Borini A; Bordes V; Frith L; Van Moer E; Germeyer A
Crit Rev Oncol Hematol; 2019 Jun; 138():233-240. PubMed ID: 31092380
[TBL] [Abstract][Full Text] [Related]
15. A Qualitative Study on the Differences Between Trial Populations and the Approved Therapeutic Indications of Antineoplastic Agents by 3 Regulatory Agencies From 2010 to 2018.
Sumi E; Asada R; Lu Y; Ito-Ihara T; Grimes KV
Clin Ther; 2020 Feb; 42(2):305-320.e0. PubMed ID: 32008723
[TBL] [Abstract][Full Text] [Related]
16. [Oncofertility and therapeutic modalities. Survey of literature].
Sápy T; Póka R
Orv Hetil; 2017 May; 158(18):683-691. PubMed ID: 28468536
[TBL] [Abstract][Full Text] [Related]
17. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
Adis International Ltd
Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
[TBL] [Abstract][Full Text] [Related]
18. Oncofertility in Japan: advances in research and the roles of oncofertility consortia.
Suzuki N
Future Oncol; 2016 Oct; 12(20):2307-11. PubMed ID: 27531055
[TBL] [Abstract][Full Text] [Related]
19. Cancer and fertility preservation: international recommendations from an expert meeting.
Lambertini M; Del Mastro L; Pescio MC; Andersen CY; Azim HA; Peccatori FA; Costa M; Revelli A; Salvagno F; Gennari A; Ubaldi FM; La Sala GB; De Stefano C; Wallace WH; Partridge AH; Anserini P
BMC Med; 2016 Jan; 14():1. PubMed ID: 26728489
[TBL] [Abstract][Full Text] [Related]
20. Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium.
Drugs R D; 2007; 8(5):321-34. PubMed ID: 17767397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
